相关实验视频

Updated: Jun 23, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.4K

在感染艾滋病毒,患有质母细胞瘤的患者中使用 pembrolizumab

Carlen A Yuen1, Silin Bao2, Melike Pekmezci3

  • 1Department of Neurology, Neuro-Oncology Division, University of California, Irvine, CA 92868, USA.

Immunotherapy
|June 18, 2024
PubMed
概括

这项研究报告了第一个患有人类免疫缺陷病毒 (HIV) 和质母细胞瘤的人被用 pembrolizumab 免疫治疗的病例. 治疗是安全的,耐受性很好,呈现混合反应,没有副作用.

关键词:
艾滋病病毒 艾滋病病毒 艾滋病病毒艾滋病毒潜伏时间HIV潜伏时间艾滋病病毒储备库是艾滋病病毒的储备库.在PD-1中使用PD-1.癌症的差异和差异 癌症的差异质母细胞瘤是一种质母细胞瘤.人类免疫缺陷病毒人类免疫缺陷病毒免疫疗法 免疫疗法这就是Pembrolizumab.编程细胞死亡1 抑制剂

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.0K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511